HCMT
Highland Capital Management (Texas) Portfolio holdings
AUM
$39M
This Quarter Return
+7.24%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.88B
AUM Growth
+$1.88B
(+5.9%)
Cap. Flow
+$8.42M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
27.06%
Holding
378
New
146
Increased
55
Reduced
43
Closed
78
Top Buys
| 1 |
TWTR
Twitter, Inc.
TWTR
|
$97.8M |
| 2 |
AstraZeneca
AZN
|
$26.5M |
| 3 |
Hain Celestial
HAIN
|
$17.8M |
| 4 |
SBA Communications
SBAC
|
$17.4M |
| 5 |
Microsoft
MSFT
|
$16.9M |
Top Sells
| 1 |
Salesforce
CRM
|
$120M |
| 2 |
American Airlines Group
AAL
|
$60.7M |
| 3 |
Dollar General
DG
|
$27.7M |
| 4 |
Sabre
SABR
|
$22M |
| 5 |
PCO
Pendrell Corporation - Class A
PCO
|
$19.9M |
Sector Composition
| 1 | Healthcare | 19.95% |
| 2 | Energy | 17.42% |
| 3 | Communication Services | 9.66% |
| 4 | Technology | 9.51% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Mr. Cooper
COOP
$12.1B
| $24K | ﹤0.01% | 10,310 | – | – |
|
277
Medtronic
MDT
$119B
| – | – | -58,900 | Closed | -$5.11M |
|
278
Marvell Technology
MRVL
$54.2B
| – | – | -80,050 | Closed | -$763K |
|
279
Newell Brands
NWL
$2.48B
| – | – | -174,404 | Closed | -$8.47M |
|
280
Oracle
ORCL
$635B
| – | – | -10,000 | Closed | -$409K |
|
281
Pan American Silver
PAAS
$12.3B
| – | – | -15,000 | Closed | -$247K |
|
282
PG&E
PCG
$33.6B
| – | – | -5,000 | Closed | -$320K |
|
283
Pfizer
PFE
$141B
| – | – | -274,200 | Closed | -$9.66M |
|
284
Pool Corp
POOL
$11.6B
| – | – | -4,000 | Closed | -$376K |
|
285
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
286
Agilent Technologies
A
$35.7B
| – | – | -115,700 | Closed | -$5.13M |
|
287
AbbVie
ABBV
$372B
| – | – | -122,010 | Closed | -$7.55M |
|
288
Alerian MLP ETF
AMLP
$10.7B
| – | – | 0 | – | – |
|
289
Alexandria Real Estate Equities
ARE
$14.1B
| – | – | -81,000 | Closed | -$8.39M |
|
290
AutoZone
AZO
$70.2B
| – | – | -12,007 | Closed | -$9.53M |
|
291
Ball Corp
BALL
$14.3B
| – | – | -34,788 | Closed | -$2.52M |
|
292
Bausch Health
BHC
$2.74B
| – | – | -57,500 | Closed | -$1.16M |
|
293
Biogen
BIIB
$19.4B
| – | – | 0 | – | – |
|
294
Bristol-Myers Squibb
BMY
$96B
| – | – | -6,000 | Closed | -$441K |
|
295
Chubb
CB
$110B
| – | – | -2,000 | Closed | -$261K |
|
296
Clorox
CLX
$14.5B
| – | – | -2,000 | Closed | -$277K |
|
297
Centene
CNC
$14.3B
| – | – | -97,851 | Closed | -$6.98M |
|
298
CommScope
COMM
$3.55B
| – | – | -326,200 | Closed | -$10.1M |
|
299
Chevron
CVX
$324B
| – | – | -4,000 | Closed | -$419K |
|
300
Delta Air Lines
DAL
$40.3B
| – | – | -36,206 | Closed | -$1.32M |
|